Samenvatting
Despite its success in multiple tumor types, immunotherapy remains poorly efficacious in brain malignancies. In this issue of Cell, Friebel et al. and Klemm et al. provide in-depth insights into the versatile nuances of immune cells in primary and metastatic brain tumors, granting the field with a rich framework to explore novel therapeutic avenues.
Originele taal-2 | Engels |
---|---|
Pagina's (van-tot) | 1454-1457 |
Aantal pagina's | 4 |
Tijdschrift | Cell |
Volume | 181 |
Nummer van het tijdschrift | 7 |
DOI's | |
Status | Gepubliceerd - 25 jun. 2020 |